ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Health Policy: Organ Procurement Should Cover Wider Areas, IOM Report Says

August 6, 1999

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

NCI Advisory Group Meetings for July

June 27, 1975

CCOP Applications Total 162; Three Committees, Headed By Ahmann, Loeb, Spur Will Review Them

November 19, 1982